Provider-prescribed weight loss programs utilizing GLP-1–based therapies, including tirzepatide — evaluated and supervised by our physician following a comprehensive clinical assessment.
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It is the active pharmaceutical ingredient in branded medications including Mounjaro and Zepbound, which are FDA-approved products for specific indicated uses.
At DuPage Medical Wellness, our programs may include medications prescribed based on individual patient needs. Your provider determines the appropriate treatment following a full clinical evaluation. Compounded formulations are not FDA-approved.
Published research on the FDA-approved branded medication Zepbound (tirzepatide) demonstrated outcomes in trial participants. These results reflect the studied branded formulation and may not apply to compounded versions.
Read the Published StudyMeet with our physician to review your health history, goals, and candidacy for treatment
Comprehensive blood panel and metabolic review before any prescription is issued
If indicated, start your prescribed program with a personalized titration schedule
Progress check-ins with 3D body scan and medication adjustments as needed
In-clinic in Naperville or via telehealth.
Or call us at 630-857-9333
